Subclinical Carotid Atherosclerosis in HIV-Infected Patients

Abstract

CART should be considered a strong, independent predictor for the development of subclinical atherosclerosis in HIV-infected patients, regardless of known major cardiovascular risk factors and atherogenic metabolic abnormalities induced by this therapy.